Macleaya cordata extract improves growth performance, immune responses and anti-inflammatory capacity in neonatal piglets

Macleaya cordata was a kind of traditional herbal medicine, which may a potential substitute for antibiotics. However, the effects of Macleaya cordata on neonatal piglets have rarely been reported. In this study, three groups were designed, including normal saline (Control group, CON), 8 mg/mL Macleaya cordata extract (MCE group, MCE) and 5 mg/mL Chlortetracycline Hydrochloride (CCH group, CCH), to investigate the effects of MCE on growth performance, blood parameters, inflammatory cytokines, regenerating islet-derived 3 gamma (REG3 gamma) gamma ) expression and the transcriptomes of neonatal piglets. The results showed that, compared with the control group, MCE significantly increased the average daily gain (p p < 0.01); spleen index (p p < 0.05) contents of IL-10, TGF-beta, beta, IgG in serum and sIgA in the ileum mucus of neonatal piglets at 7 d and 21 d (p p < 0.01). The diarrhoea incidence and serum TNF-alpha and IFN-gamma gamma contents of neonatal piglets at 7 d and 21 d were significantly decreased (p p < 0.01). In addition, MCE significantly increased the mRNA expression of TGF-beta, beta, IL-10, and REG3 gamma gamma (p p < 0.01) and significantly decreased the mRNA expression of IL-33, TNF-alpha and IFN-gamma gamma in the ileal mucosa of neonatal piglets at 21 d (p p < 0.01). The differentially expressed genes and the signal pathways, related to cytokine generation and regulation, immunoregulation and inflammation were identified. In conclusion, MCE can significantly improve growth performance, reduce diarrhoea incidence, relieve inflammation, improve immune function, and improve disease resistance in neonatal piglets. MCE can be used as a potential substitute for antibiotics in neonatal piglets.